Skip to content

Surgery Partners, Inc. SGRY Finance Lease, Right-of-Use Asset, after Accumulated Amortization

Finance Lease, Right-of-Use Asset, after Accumulated Amortization at other companies

Solventum logo
SolventumSOLV
PACS Group logo
PACS GroupPACS

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.9B-49.1%
Enterprise value$6.77B-16.0%
P/S0.6×-0.6×

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAsset.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s finance lease, right-of-use asset, after accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Surgery Partners, Inc.'s finance lease, right-of-use asset, after accumulated amortization?
Surgery Partners, Inc. (SGRY) reported finance lease, right-of-use asset, after accumulated amortization of $725.4M in Q1 2026.
How has Surgery Partners, Inc.'s finance lease, right-of-use asset, after accumulated amortization changed year-over-year?
Surgery Partners, Inc.'s finance lease, right-of-use asset, after accumulated amortization increased by 1.2% year-over-year, from $716.8M to $725.4M.
What is the long-term trend for Surgery Partners, Inc.'s finance lease, right-of-use asset, after accumulated amortization?
Over 4 years (2021 to 2025), Surgery Partners, Inc.'s finance lease, right-of-use asset, after accumulated amortization has grown at a 22.4% compound annual growth rate (CAGR), from $329.6M to $740.4M.